PUBLICATIONS

Through its publications, INSS aims to provide expert insights, cutting-edge research, and innovative solutions that contribute to shaping the national security discourse and preparing the next generation of leaders in the field.

 

Publications

Results:
Tag: synthetic biology

Dec. 22, 2025

Biotechnologies and the Treaty Gap: Why Biological Weapons Governance Is Falling Behind; and Some Thoughts on How to Fix It

The Scottish ballad Auld Lang Syne, written in 1788 by poet Robert Burns is a tune traditionally played to ring out the passing year and herald in the new. The lyrics offer an invitation to celebrate that which was good, and toast to what may come.

Feb. 19, 2025

Drones and Biotechnological Weaponry: Emerging Risks, Strategic Threats, and Viable Readiness

The United States National Drone Association (USNDA) recently announced its sponsorship of the inaugural, international U.S. Military Drone Crucible Drone Championship to provide a venue for exercising U.S. and allied military drone training, advanced piloting, operational utility, and counter-measures’ capability.

Dec. 2, 2019

Synthetic Biology Industry Practices and Opportunities for Biosecurity and Potential Roles for the U.S. Government

This report summarizes discussions with industry representatives about the current and future structure of the synthetic biology industry, perspectives on potential misuse and vulnerabilities of synthetic biology tools and capabilities, and business practices to prevent misuse of tools and to protect industry assets.

April 4, 2018

Biodata Risks and Synthetic Biology: A Critical Juncture

Intrinsic to growing ability to apply classical engineering to biological systems is the mounting ‘digitization of biology’, as the genetic code and its related metadata (including translated proteins, associated functions, herein referred to as “biodata”) are amassed in order to engineer biology for specific purposes. There are three unique risks categories associated with the digitization of biology: 1) pathogen risks; 2) manufacturing risks, and 3) risks to individual privacy that can allow human harms.